Literature DB >> 26799063

Hepatocellular Carcinoma Cells Induce Regulatory T Cells and Lead to Poor Prognosis via Production of Transforming Growth Factor-β1.

Yi Wang1, Taotao Liu, Wenqing Tang, Bin Deng, Yanjie Chen, Jimin Zhu, Xizhong Shen.   

Abstract

BACKGROUND/AIMS: Regulatory T cells (Tregs) are associated with a poor prognosis in hepatocellular carcinoma (HCC). The purpose of the study was to explore the mechanisms of Tregs accumulation in HCC.
METHODS: We analyzed the frequency of Tregs in HCC by flow cytometry and immunohistochemistry. We also established a transforming growth factor (TGF)-β1-knockdown cell line by lentivirus-mediated RNA interference. Mouse CD4+CD25- T cells were cultured in supernatants from various cell lines.
RESULTS: HCC patients had a high frequency of Tregs, and high numbers of Tregs correlated with a poor prognosis. Liver cancer cells induced Treg production by secreting TGF-β1. In vivo experiments indicated that knockdown of TGF-β1 reduced the numbers of Tregs and metastatic nodules in mice.
CONCLUSIONS: These results indicate that cancer-secreted TGF-β1 may increase Tregs, and TGF-β1 knockdown might impair immunosuppression in the tumor microenvironment by decrease Tregs.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26799063     DOI: 10.1159/000438631

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  26 in total

Review 1.  Engineered Niches to Analyze Mechanisms of Metastasis and Guide Precision Medicine.

Authors:  Aaron H Morris; Sophia M Orbach; Grace G Bushnell; Robert S Oakes; Jacqueline S Jeruss; Lonnie D Shea
Journal:  Cancer Res       Date:  2020-05-14       Impact factor: 12.701

Review 2.  Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma.

Authors:  Laura Amicone; Alessandra Marchetti
Journal:  Transl Gastroenterol Hepatol       Date:  2018-05-02

3.  Hepatic Artery Embolization Induces the Local Overexpression of Transforming Growth Factor β1 in a Rat Hepatoma Model.

Authors:  Eisuke Ueshima; Hideyuki Nishiofuku; Haruyuki Takaki; Yutaka Hirata; Hiroshi Kodama; Toshihiro Tanaka; Kimihiko Kichikawa; Koichiro Yamakado; Takuya Okada; Keitaro Sofue; Masato Yamaguchi; Koji Sugimoto; Takamichi Murakami
Journal:  Liver Cancer       Date:  2019-10-16       Impact factor: 11.740

4.  Absolute Lymphocyte Count, Platelet-to-Lymphocyte Ratio, and Overall Survival in Eribulin-treated HER2-negative Metastatic Breast Cancer Patients.

Authors:  Yoichi Koyama; Saori Kawai; Natsuki Uenaka; Miki Okazaki; Mariko Asaoka; Saeko Teraoka; A I Ueda; Kana Miyahara; Takahiko Kawate; Hiroshi Kaise; Kimito Yamada; Takashi Ishikawa
Journal:  Cancer Diagn Progn       Date:  2021-11-03

5.  High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis via Regulating Tumor Immunity.

Authors:  Xiuli Jin; Shuairan Zhang; Ningning Wang; Lin Guan; Chuanli Shao; Yingbo Lin; Jianping Liu; Yiling Li
Journal:  Front Oncol       Date:  2022-04-25       Impact factor: 5.738

Review 6.  TGFB1/INHBA Homodimer/Nodal-SMAD2/3 Signaling Network: A Pivotal Molecular Target in PDAC Treatment.

Authors:  Mai Abdel Mouti; Siim Pauklin
Journal:  Mol Ther       Date:  2021-01-09       Impact factor: 11.454

Review 7.  The Functional Roles of Immune Cells in Primary Liver Cancer.

Authors:  Linh Pham; Konstantina Kyritsi; Tianhao Zhou; Ludovica Ceci; Leonardo Baiocchi; Lindsey Kennedy; Sanjukta Chakraborty; Shannon Glaser; Heather Francis; Gianfranco Alpini; Keisaku Sato
Journal:  Am J Pathol       Date:  2022-03-23       Impact factor: 5.770

8.  High SEC61G expression predicts poor prognosis in patients with Head and Neck Squamous Cell Carcinomas.

Authors:  Leifeng Liang; Qingwen Huang; Mei Gan; Liujun Jiang; Haolin Yan; Zhan Lin; Haisheng Zhu; Rensheng Wang; Kai Hu
Journal:  J Cancer       Date:  2021-05-05       Impact factor: 4.207

9.  TGF-β1 Induces Immune Escape by Enhancing PD-1 and CTLA-4 Expression on T Lymphocytes in Hepatocellular Carcinoma.

Authors:  Shixiang Bao; Xiaopei Jiang; Shuai Jin; Peipei Tu; Jingtao Lu
Journal:  Front Oncol       Date:  2021-06-25       Impact factor: 6.244

10.  Mechanism of action and efficacy of LY2109761, a TGF-β receptor inhibitor, targeting tumor microenvironment in liver cancer after TACE.

Authors:  Xiaojun He; Xiaopeng Guo; Hongsen Zhang; Xiangchuang Kong; Fan Yang; Chuansheng Zheng
Journal:  Oncotarget       Date:  2017-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.